M
MedCPU
MedCPU delivers real-time clinical care advice to hospitals in the United States through its advanced Advisor technology
About MedCPU
MedCPU is a healthcare technology company that provides real-time clinical decision support solutions to hospitals and healthcare providers in the United States. The company's core product is the Advisor technology, a platform that captures and analyzes clinical data from any Electronic Medical Record (EMR) system in real-time, without the need for complex HL7 integrations. This allows the platform to provide clinicians with immediate, evidence-based advice and alerts at the point of care, helping to improve the quality of patient care, ensure compliance with clinical guidelines, and optimize clinical documentation.
The business model is based on providing its software and services to hospitals. The company's revenue is generated through subscriptions to its platform. MedCPU's target clients are hospitals and healthcare systems that are looking to enhance their clinical decision-making processes and improve patient outcomes. The company operates in the digital health and clinical decision support market, a sector that is experiencing significant growth as healthcare organizations increasingly adopt technology to improve efficiency and quality of care.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- New York City, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 60.3/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Testing, Verification, Speech Recognition, Data Analytics, Decision Making, Health Information, Patient Care, Core AI, Hospital, Hard Tech, AI Applications, Health It
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | May 2016 | $35M | $140M | UPMC Enterprises · Merck Global Health Innovation Fund | — |
| DEBTDebt | Jul 2015 | $35M | — | Silicon Valley Bank | — |
Growth signals
Latest recorded traffic for MedCPU is 5.4K monthly website visits, down 70% over the last three months. MedCPU's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Easton Capital Investment Group
Merck Global Health Innovation Fund
NRV
UPMC Enterprises
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedCPU on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedCPU’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.